Visceral leishmaniasis: elimination with existing interventions.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21453873.
- Also identified by DOI 10.1016/S1473-3099(10)70320-0.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The world's burden of infectious diseases can be substantially reduced by more-effective use of existing interventions. Advances in case detection, diagnosis, and treatment strategies have made it possible to consider the elimination of visceral leishmaniasis in the Indian subcontinent. The priority must now be to effectively implement existing interventions at the community level by actively finding cases in endemic villages and treating them with single-dose liposomal amphotericin B at primary-health-care centres. Once the elimination target of one case per 10,000 population has been reached, combination therapies involving miltefosine and paromomycin can be introduced to ensure long-term availability of several drugs for visceral leishmaniasis and to protect against resistance.
Medical subject headings
- Antiprotozoal Agents
- Communicable Disease Control
- Leishmaniasis, Visceral